Return to homepagePandemic Pact

To manufacture Omicron variant SARS-CoV-2 virus to support the development of low-cost effective mucosal vaccines.

Grant number: INV-063944

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2023

  • Known Financial Commitments (USD)

    $1,873,800

  • Funder

    Gates Foundation

  • Research Location

    France

  • Lead Research Institution

    Naobios

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

N/A